Navigation Links
How to confirm the causes of iron deficiency anemia in young women
Date:6/23/2009

Iron-deficiency anaemia (IDA) is commonly seen in women aged <50 years. The diagnostic workflow in young women affected by IDA is not clearly established. The British Society of Gastroenterology recommends gastroscopy only in IDA women younger than 45 years presenting with gastrointestinal (GI) symptoms. However, symptoms are often mild and aspecific in IDA women and the gastroscopy is an invasive procedure associated with a high number of refusals. In a previous work on IDA premenopausal women, gastroscopy was performed in all patients, later deemed unnecessary in almost 30% of the studied women because these were affected only by menorrhagia.

A research team led by Bruno Annibale from Italy prospectively evaluate the usefulness of a pre-endoscopic serological screening for H. pylori infection and celiac disease with the use of two tests (human recombinant tissue transglutaminase IgA antibodies and anti-H. pylori IgG antibodies) in women aged < 50 affected by IDA in order to increase the compliance for gastroscopy. Their study will be published on June 14, 2009 in the World Journal of Gastroenterology

In this study, 115 women aged < 50 years with IDA were tested by human recombinant tissue transglutaminase IgA antibodies (tTG) and anti-H. pylori IgG antibodies. All cases underwent gastroscopy with biopsies of stomach and duodenum, irrespective of tests results. Of the 115 patients, 45.2% of women were test-positive. The serological results were confirmed by gastroscopy in 100% of those with positive H. pylori antibodies, in 50% of those with positive tTG and in 81.5% of test-negative patients. Sensitivity and specificity were 84.8% and 100% for H. pylori infection, and 80% and 92.8% for tTG, respectively. The gastroscopy compliance rate of test-positive women was significantly increased in comparison with those test-negative (65.4% vs 42.8%; Fisher test P = 0.0239).

This study showed that two simp
'/>"/>

Contact: Lai-Fu Li
wjg@wjgnet.com
86-105-908-0039
World Journal of Gastroenterology
Source:Eurekalert

Page: 1 2

Related medicine news :

1. GAO Report Confirms: Medicare Underpays for Anesthesia Services; Nurse Anesthetists Assure Seniors Access to Safe Anesthesia Care
2. University of Texas Study Details Lengthy Payment Delays for Medicare Part D Prescription Drug Claims, Confirming Need for Legislative Fix
3. University of Nevada School of Medicine Professor Confirms Accuracy Through Validation Study Using the CSI Health Station Model 6K
4. PA Game Commission: EHD Outbreak Update: Test Results Confirm EHD In Beaver County
5. Actavis Confirms its Patent Challenge of Kings Avinza(R)
6. Barr Confirms Patent Challenge of UROXATRAL(R)
7. Pennsylvania Game Commission Announces EHD Confirmed in Allegheny and Westmoreland Counties
8. Perrigo Confirms Filing for Generic Version of Mucinex(R) and Announcement of Lawsuit by Adams Respiratory
9. Use of Technology to Document Comorbid Conditions May Improve Reimbursement, Increase Documentation Accuracy Study Confirms
10. Newly Published Study in Leading Medical Journal Further Confirms the Brava Systems Non-Surgical Breast Enhancement Effectiveness
11. LUNA Pure Prevention Survey Confirms Breast Cancer Misconceptions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... ... 2015 , ... The Nashville Business Journal recently announced its ... Mr. Troy Mizell, Chairman of the Board at MyGenetx, is one of ... Awards will recognize Nashville military veterans who, through their professional and personal efforts, ...
(Date:8/28/2015)... Arizona (PRWEB) , ... August 28, 2015 , ... ... and increased patient loyalty at a low cost. Personalized with practice contact information ... and existing patients. Dental offices can also incorporate Calendars into seasonal mailings, thank ...
(Date:8/28/2015)... ... ... Mendon, IL, home of the Adams County Fairgrounds, was treated once again ... cause. In its second year, the “Music With A Mission” benefit concert was held ... of “Music With A Mission” is to raise money to help fund music education ...
(Date:8/28/2015)... ... 2015 , ... The Louis W. Sullivan Institute for ... transform quality and efficiency of healthcare delivery worldwide, announced the release of a ... being publicly shared to document progress and inform policy in a report issued ...
(Date:8/28/2015)... ... August 28, 2015 , ... United Benefit Advisors ... TJS Insurance Group as its newest Partner Firm. Founded in 1924 and headquartered ... them focused on their goals. Within the past 10 years, TJS Insurance Group ...
Breaking Medicine News(10 mins):Health News:MyGenetx Board Member Receives Veterans Award 2Health News:SmartPractice® Introduces 2016 Calendars for Dental Practice Giveaways 2Health News:Best Drug Rehabilitation Sponsors "Music With A Mission" Concert Featuring Avenue Beat 2Health News:WEDI's The Sullivan Institute for Healthcare Innovation Releases Gaps in Care Survey 2Health News:TJS Insurance Group Is Latest Partner Firm To Join United Benefit Advisors 2Health News:TJS Insurance Group Is Latest Partner Firm To Join United Benefit Advisors 3
... 21 Rigel,Pharmaceuticals, Inc. (Nasdaq: RIGL ) ... in conjunction with the American College of,Rheumatology Meeting ... Members of Rigel,s senior management team will provide ... a novel, oral Syk kinase,inhibitor. R788 is currently ...
... the,availability of MarketStats for health care technology equities ... a perspective on the,aforementioned equities and the opportunity ... Investors can view MarketStats by visiting: ... social networking site for,investors., Today,s MarketStats for ...
... Aid, an application for iPhone and iPod Touch, is released today ... the steps of Cardiopulmonary Resuscitation or how to act when someone ... ... 2008 -- Phone Aid, an application for iPhone and iPod Touch, ...
... has expanded the reach of its custom commercial printing by ... Canada and Europe. , ... Ft. ... commercial printing customers with international shipping options via FedEx, UPS ...
... Unchanged, ST. LOUIS, Oct. 20 KV Pharmaceutical ... Hologic, Inc., the,holder of the New Drug Application (NDA) ... has extended the PDUFA date on,Gestiva(TM) for ninety days ... extension is in line with the FDA,s standard operating ...
... heart attacks , , MONDAY, Oct. 20 (HealthDay News) -- A ... reduce the risks of surgery. , The death rate for ... higher in the 30 days after an operation than for ... according to a report in the October issue of the ...
Cached Medicine News:Health News:Rigel to Webcast Investor Update on October 27, 2008 2Health News:SectorWatch.biz Issues MarketStats on NWCI, ERES, STJ, MDT, BSX, and CSCX 2Health News:Save Lives with Your Mobile Phone - Doctor Releases First Aid Application for iPhone 2Health News:My1Stop.com Takes Commercial Printing Global with International Shipping of Custom Printed Products 2Health News:KV Provides Update on Gestiva(TM) PDUFA Date 2Health News:KV Provides Update on Gestiva(TM) PDUFA Date 3Health News:KV Provides Update on Gestiva(TM) PDUFA Date 4Health News:Questions Continue About Using Beta Blockers Before Surgery 2Health News:Questions Continue About Using Beta Blockers Before Surgery 3
(Date:8/28/2015)... 2015 According to a new ... Lung, Prostate) Type (Protein & Genetic Biomarkers) Profiling Technology ... & Geography - Global Forecast to 2020", published by ... around 17,689.0 Million USD by 2020 at a CAGR ... 2020. Browse 191 Tables and 38 ...
(Date:8/28/2015)... 28, 2015 Research ... addition of the "Investigation Report on China,s ... Originally discovered by Welfide (Mitsubishi Tanabe ... Ltd) as an inflammatory drug, pranoprofen was later ... Ltd under the trade name of pranopulin for ...
(Date:8/28/2015)... DUBLIN , Aug. 28, 2015 ... announced the addition of the "Investigation Report on ... Developed by Roche under the trade name ... in the world. In Feb.26, 2010, it was approved ... injections available in China all ...
Breaking Medicine Technology:Cancer Biomarkers Market Worth 17,689.0 Million USD by 2020 2Cancer Biomarkers Market Worth 17,689.0 Million USD by 2020 3Cancer Biomarkers Market Worth 17,689.0 Million USD by 2020 4Cancer Biomarkers Market Worth 17,689.0 Million USD by 2020 5Investigation Report on China's Pranoprofen Market, 2010-2019 2Investigation Report on China's Bevacizumab Market 2015-2019 2
... from Serial Outpatient Infusion Study in Patients with,Chronic ... Cardiology 56th Annual Scientific Session --, MOUNTAIN VIEW, ... Scios Inc. announced today that an exploratory,920-patient, Phase ... on the primary endpoint, a composite of death ...
... March 25, 2007 /PRNewswire/ -- Once-daily,dosing with ... antagonist, was associated with improvements,in signs and ... hospitalized patients receiving conventional care, without an,adverse ... These,data are from the short- and long-term ...
Cached Medicine Technology:Scios Announces Results From Exploratory Nesiritide Study Providing,Important New Renal and Mortality Safety Data with a Neutral Effect,on the Primary Endpoint 2Scios Announces Results From Exploratory Nesiritide Study Providing,Important New Renal and Mortality Safety Data with a Neutral Effect,on the Primary Endpoint 3Scios Announces Results From Exploratory Nesiritide Study Providing,Important New Renal and Mortality Safety Data with a Neutral Effect,on the Primary Endpoint 4Scios Announces Results From Exploratory Nesiritide Study Providing,Important New Renal and Mortality Safety Data with a Neutral Effect,on the Primary Endpoint 5Scios Announces Results From Exploratory Nesiritide Study Providing,Important New Renal and Mortality Safety Data with a Neutral Effect,on the Primary Endpoint 6Scios Announces Results From Exploratory Nesiritide Study Providing,Important New Renal and Mortality Safety Data with a Neutral Effect,on the Primary Endpoint 7Everest Data on Short- and Long-Term Use of Otsuka's,Investigational Novel Treatment, Tolvaptan, Published in Journal of,the American Medical Association and Featured in ACC's Late,Breaking Clinical Trials 2Everest Data on Short- and Long-Term Use of Otsuka's,Investigational Novel Treatment, Tolvaptan, Published in Journal of,the American Medical Association and Featured in ACC's Late,Breaking Clinical Trials 3Everest Data on Short- and Long-Term Use of Otsuka's,Investigational Novel Treatment, Tolvaptan, Published in Journal of,the American Medical Association and Featured in ACC's Late,Breaking Clinical Trials 4Everest Data on Short- and Long-Term Use of Otsuka's,Investigational Novel Treatment, Tolvaptan, Published in Journal of,the American Medical Association and Featured in ACC's Late,Breaking Clinical Trials 5Everest Data on Short- and Long-Term Use of Otsuka's,Investigational Novel Treatment, Tolvaptan, Published in Journal of,the American Medical Association and Featured in ACC's Late,Breaking Clinical Trials 6Everest Data on Short- and Long-Term Use of Otsuka's,Investigational Novel Treatment, Tolvaptan, Published in Journal of,the American Medical Association and Featured in ACC's Late,Breaking Clinical Trials 7
Resorbable fixation system 1.5/2.0....
... By combining intra-operative ... imagery, Medtronic Surgical Navigation ... revolutionary product called SonoNav ... system built on the ...
... the two steps are performed in sequence ... single use disposable cartridge and placed in ... touches a button, and the cycle begins. ... Then the integral syringe pump concentrates fibrinogen, ...
Avitene Microfibrillar Collagen Hemostat (MCH) is used in surgical procedures as an adjunct to hemostasis when control of bleeding by ligature or conventional procedures is ineffective or impractical...
Medicine Products: